Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nature Reviews Drug Discovery | journal | 11.296 Q1 | 391 | 243 | 686 | 7395 | 11657 | 235 | 17.10 | 30.43 | |
2 | Nano Today | journal | 3.890 Q1 | 175 | 239 | 235 | 25951 | 4471 | 229 | 17.54 | 108.58 | |
3 | Journal for ImmunoTherapy of Cancer | journal | 3.450 Q1 | 117 | 551 | 994 | 23687 | 12239 | 988 | 10.91 | 42.99 | |
4 | Trends in Pharmacological Sciences | journal | 3.389 Q1 | 244 | 89 | 294 | 7484 | 3719 | 284 | 11.92 | 84.09 | |
5 | Emerging Microbes and Infections | journal | 3.322 Q1 | 94 | 225 | 678 | 9428 | 9223 | 559 | 16.50 | 41.90 | |
6 | npj Vaccines | journal | 2.953 Q1 | 47 | 150 | 205 | 8502 | 1723 | 196 | 8.66 | 56.68 | |
7 | Advanced Drug Delivery Reviews | journal | 2.934 Q1 | 366 | 324 | 467 | 70877 | 8309 | 434 | 16.58 | 218.76 | |
8 | Natural Product Reports | journal | 2.780 Q1 | 211 | 106 | 218 | 19553 | 2848 | 211 | 13.07 | 184.46 | |
9 | Protein and Cell | journal | 2.636 Q1 | 94 | 84 | 300 | 4240 | 2427 | 173 | 6.21 | 50.48 | |
10 | Cellular and Molecular Life Sciences | journal | 2.424 Q1 | 261 | 454 | 909 | 58205 | 9414 | 900 | 10.10 | 128.20 | |
11 | Neuropsychopharmacology | journal | 2.277 Q1 | 249 | 307 | 900 | 17484 | 6385 | 811 | 6.74 | 56.95 | |
12 | Antiviral Research | journal | 2.213 Q1 | 151 | 139 | 647 | 6856 | 6147 | 646 | 10.60 | 49.32 | |
13 | Environmental Pollution | journal | 1.954 Q1 | 301 | 2368 | 5208 | 159916 | 50628 | 5169 | 9.21 | 67.53 | |
14 | Journal of Controlled Release | journal | 1.812 Q1 | 313 | 631 | 1507 | 58115 | 16374 | 1448 | 10.87 | 92.10 | |
15 | Neurotherapeutics | journal | 1.725 Q1 | 136 | 192 | 349 | 14401 | 2559 | 325 | 5.68 | 75.01 | |
16 | Expert Review of Vaccines | journal | 1.689 Q1 | 105 | 137 | 298 | 12252 | 1688 | 279 | 5.13 | 89.43 | |
17 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.610 Q1 | 99 | 13 | 46 | 1844 | 403 | 44 | 7.96 | 141.85 | |
18 | Journal of Nanobiotechnology | journal | 1.557 Q1 | 109 | 438 | 391 | 28040 | 4765 | 391 | 8.76 | 64.02 | |
19 | Clinical Trials | journal | 1.550 Q1 | 74 | 89 | 265 | 2369 | 585 | 223 | 1.85 | 26.62 | |
20 | BioDrugs | journal | 1.539 Q1 | 79 | 52 | 183 | 4351 | 1267 | 173 | 7.33 | 83.67 | |
21 | Journal of Antimicrobial Chemotherapy | journal | 1.495 Q1 | 221 | 538 | 1687 | 16358 | 8914 | 1460 | 4.84 | 30.41 | |
22 | Acta Pharmacologica Sinica | journal | 1.472 Q1 | 117 | 200 | 522 | 11159 | 4049 | 513 | 7.24 | 55.80 | |
23 | Drug Discovery Today | journal | 1.470 Q1 | 215 | 280 | 724 | 23276 | 6308 | 669 | 8.11 | 83.13 | |
24 | Human Genomics | journal | 1.456 Q1 | 68 | 71 | 160 | 3876 | 915 | 155 | 6.16 | 54.59 | |
25 | Therapeutic Advances in Neurological Disorders | journal | 1.447 Q1 | 68 | 101 | 224 | 4769 | 1467 | 213 | 6.18 | 47.22 | |
26 | Expert Opinion on Therapeutic Targets | journal | 1.444 Q1 | 106 | 88 | 285 | 9875 | 1809 | 258 | 5.72 | 112.22 | |
27 | Drug and Alcohol Dependence | journal | 1.438 Q1 | 187 | 691 | 1493 | 32861 | 6803 | 1471 | 4.31 | 47.56 | |
28 | Particle and Fibre Toxicology | journal | 1.437 Q1 | 119 | 48 | 154 | 3323 | 1310 | 153 | 8.01 | 69.23 | |
29 | Current Opinion in Systems Biology | journal | 1.420 Q1 | 34 | 80 | 193 | 5031 | 642 | 173 | 3.07 | 62.89 | |
30 | International Journal of Neuropsychopharmacology | journal | 1.417 Q1 | 125 | 114 | 248 | 7218 | 1419 | 245 | 5.39 | 63.32 | |
31 | npj Systems Biology and Applications | journal | 1.390 Q1 | 35 | 45 | 111 | 3081 | 566 | 110 | 4.09 | 68.47 | |
32 | Addictive Behaviors | journal | 1.372 Q1 | 149 | 413 | 1204 | 20563 | 5119 | 1168 | 4.01 | 49.79 | |
33 | CNS Neuroscience and Therapeutics | journal | 1.364 Q1 | 91 | 148 | 405 | 8013 | 2398 | 355 | 6.36 | 54.14 | |
34 | Inflammation Research | journal | 1.332 Q1 | 107 | 100 | 303 | 5777 | 1955 | 293 | 6.83 | 57.77 | |
35 | European Neuropsychopharmacology | journal | 1.324 Q1 | 130 | 153 | 407 | 7505 | 1875 | 390 | 4.42 | 49.05 | |
36 | Neuropharmacology | journal | 1.323 Q1 | 191 | 332 | 1299 | 32763 | 7085 | 1278 | 5.11 | 98.68 | |
37 | Drug Discovery Today: Technologies | journal | 1.321 Q1 | 62 | 24 | 96 | 1203 | 583 | 90 | 6.63 | 50.13 | |
38 | PharmacoEconomics | journal | 1.321 Q1 | 118 | 109 | 356 | 4978 | 1417 | 310 | 3.53 | 45.67 | |
39 | Journal of Molecular Medicine | journal | 1.306 Q1 | 157 | 135 | 371 | 10566 | 1984 | 363 | 5.21 | 78.27 | |
40 | Current Opinion in Pharmacology | journal | 1.279 Q1 | 148 | 129 | 335 | 8317 | 1656 | 298 | 4.44 | 64.47 | |
41 | Clinical Pharmacokinetics | journal | 1.274 Q1 | 184 | 118 | 360 | 5753 | 2018 | 324 | 5.18 | 48.75 | |
42 | Drug Safety | journal | 1.268 Q1 | 140 | 121 | 383 | 4708 | 1757 | 325 | 4.81 | 38.91 | |
43 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.234 Q1 | 106 | 97 | 250 | 4678 | 1336 | 238 | 5.59 | 48.23 | |
44 | Biomedicine and Pharmacotherapy | journal | 1.194 Q1 | 149 | 1366 | 4433 | 107284 | 32385 | 4421 | 7.33 | 78.54 | |
45 | Expert Opinion on Investigational Drugs | journal | 1.177 Q1 | 117 | 116 | 331 | 9002 | 1793 | 313 | 5.43 | 77.60 | |
46 | Clinical and Translational Science | journal | 1.162 Q1 | 60 | 263 | 314 | 9245 | 1534 | 277 | 4.76 | 35.15 | |
47 | EPMA Journal | journal | 1.147 Q1 | 52 | 36 | 109 | 4149 | 862 | 108 | 8.81 | 115.25 | |
48 | Frontiers in Pharmacology | journal | 1.143 Q1 | 154 | 4009 | 5230 | 262406 | 33132 | 5134 | 5.69 | 65.45 | |
49 | Advanced Therapeutics | journal | 1.134 Q1 | 39 | 153 | 233 | 16392 | 1371 | 229 | 5.23 | 107.14 | |
50 | Drugs in Context | journal | 1.130 Q1 | 36 | 63 | 166 | 3820 | 1008 | 166 | 5.04 | 60.63 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®